Replies to post #96916 on OWC Pharmaceutical Research Corp (OWCP)

[BAMF31]

From the 10-K "..ownership of the common stock as of March 31, 2017"
Shmuel De-Saban, Chief Financial Officer 195,416


From the OTCQB Certification filed and is current as of June 13, 2017:
Shmuel De-Saban Petach Tikva, Israel 195,416 shares


Under the Company’s 2016 ESOP, ... 750,000 options were granted to Mr. De-Saban, ... during 2016. Subject to the provisions of applicable Israeli laws, these options are held by a trustee and vest after a period of two years and, as a result, are not included in the above table.


All execs are looking to 2018 and beyond. They have a plan, just have an understanding that it may not be YOUR plan (whatever pps target that is for you) but they have a plan. Pieces will be coming together the rest of this year.